| |
 |
|
|
Inventor: Schudok; Manfred
Address: Eppstein/Ts, DE
No. of patents: 15
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7399770 |
Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors |
July 15, 2008 |
| The invention is directed to a compound of the formula I ##STR00001## wherein the variables are as defined herein, or a stereoisomeric form thereof, mixture of stereoisomeric forms, in any ratio, or a salt thereof.Another aspect of the present invention is directed to a pharmaceutica |
| 7205315 |
Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
April 17, 2007 |
| The present invention is directed to a compound of formula (I), or a stereoisomer or a mixture of stereoisomer thereof in any ratio, or its physiologically tolerable salt, which is useful as an inhibitor of matrix metalloproteinase. The present invention is also directed to a pharmac |
| 7160903 |
Sulfonylaminocarboxylic acids |
January 9, 2007 |
| Compounds of formula (I) ##STR00001## are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved. |
| 7153876 |
Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and t |
December 26, 2006 |
| Compounds of formula I, ##STR00001## in which R.sup.1, R.sup.2, A, and B having the definitions set forth in the claims, are valuable pharmacologically active compounds, which exhibit a strong antithrombotic effect and are suitable, for example, for treating thromboembolic diseases |
| 6743790 |
Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
June 1, 2004 |
| The present invention relates to compounds of the formula I, ##STR1##in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, A, X, m and n have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a stro |
| 6706715 |
Urea derivatives with antiproteolytic activity |
March 16, 2004 |
| The present invention relates to compounds of the formula I, ##STR1##in which R.sup.1, R.sup.2, R.sup.4, R.sup.5, D.sub.1, D.sub.2, X.sub.1, X.sub.2, X.sub.3, A and B have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compo |
| 6645992 |
Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and t |
November 11, 2003 |
| Compounds of formula I, ##STR1##in which R.sup.1, R.sup.2, A, and B having the definitions set forth in the claims, are valuable pharmacologically active compounds, which exhibit a strong antithrombotic effect and are suitable, for example, for treating thromboembolic diseases and re |
| 6500811 |
Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparat |
December 31, 2002 |
| Compounds of the formula I ##STR1##are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved. |
| 6500803 |
Factor VIIa inhibitors |
December 31, 2002 |
| The present invention relates to compounds of formula I, ##STR1##in which R.sup.1, R.sup.2, R.sup.91, R.sup.92, R.sup.93, R.sup.94, R.sup.95, R.sup.96, R.sup.97, r, s, and t have the meanings indicated in the claims. Compounds of formula I are valuable pharmacologically active compou |
| 6451824 |
Sulfonylaminocarboxylic acids |
September 17, 2002 |
| Compounds of formula (I) ##STR1##are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved. |
| 6355673 |
Substituted diaminocarboxylic acids |
March 12, 2002 |
| Compounds of formula (I) ##STR1##are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved |
| 6335333 |
N-arylsulfonylamino acid omega-amides |
January 1, 2002 |
| Compounds of the formula I: ##STR1##stereoisomeric forms, and physiologically tolerable salts thereof are suitable for the production of pharmaceuticals for the therapy and prophylaxis of disorders involving matrix-degrading metalloproteinases. |
| 6201130 |
N-arylsulfonylamino acid omega-amides |
March 13, 2001 |
| Compounds of the formula I: ##STR1##stereoisomeric forms, and physiologically tolerable salts thereof are suitable for the production of pharmaceuticals for the therapy and prophylaxis of disorders involving matrix-degrading metalloproteinases. |
| 6159995 |
Substituted diaminocarboxylic acids |
December 12, 2000 |
| Compounds of formula (I) ##STR1## are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved. |
| 5962471 |
Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids |
October 5, 1999 |
| Compounds of the formula I ##STR1## are suitable for the preparation of pharmaceuticals for the prophylaxis and therapy of disorders involving increased activity of matrix-degrading metalloproteinases. |
|
|
|
